Clinical Topics   /   Oncology

Just the Beginning: Genomics Research Now Used to Identify, Treat Diseases

By U.S. Medicine

BETHESDA, MD — A wave of genetic research projects sparked by last decade’s completion of the Human Genome Project are slowly making their way to fruition. Researchers, many of whom are based at NIH, are busy teasing apart the genetic mechanisms that contribute to disease, as well as finding ways to give physicians the ability to use genomic data to directly treat patients.

The Cancer Genome Atlas

One of the largest ongoing studies into the genetics of disease, The Cancer Genome Atlas (TCGA), is mapping out the genetic changes that occur during cancer development. 

“This program is continuing to make great strides toward its ambitious goals,” National Human Genome Research Institute (NHGRI) Director Eric Green, MD, PhD, told members of NHGRI’s advisory council at a meeting last month.

TCGA has 22 tumor sequencing projects under way and expects to accrue specimens of 3,000 cancers by the end of September. The goal of examining 500 separate samples for each type of tumor has already been achieved, Green said.

“Even with the challenges of data management, TCGA will achieve its goal by the September deadline,” Green said.

Earlier this year, the TCGA research network published its findings on ovarian cancer. It represented the largest, most comprehensive analysis of any cancer to date and confirmed that mutations in a single gene are responsible for 96% of such cancers.

According to Green, TCGA will add to its collection of findings with several upcoming manuscripts, including analyses reporting the results from studies on colorectal cancer, acute myeloid leukemia, and breast cancer.

Collecting Genotypes

The Genetic-Tissue Expression Project (GTEx) is a more humble initiative, but no less important, explained epidemiologist Jeff Struewing, PhD, of NIH’s Office of Population Genomics. Its goal is to create a database looking at different genotypes and their link to genetic activity disease, as well as establishing a tissue bank for future studies.

For example, a researcher interested in cardiovascular disease could access GTEx data to view all of the genetic variants in the human genome that affect gene expression in the heart.

When this two-year pilot project was launched in October 2010, the goal was to identify a modest 160 deceased donors identified through autopsy or organ and tissue transplant programs, as well as 160 living donors. From the deceased donors, 50 tissue samples would be taken from all over the body. The living donors would donate tissue post-surgery that otherwise would be discarded.

“It was funded at this size really just to see whether this idea was feasible at all, and to see if we can get out there and get donors and get samples from them,” Struewing told the advisory council.

The project has been slow to recruit donors, however, and it was not until recent months that recruitment has seen success, with nine donors in June, five in July and 15 in August.

“The molecular quality of the data is looking very promising early on,” Struewing said.

All of this data will be placed into a common fund community resource, which will be made available to the broader scientific community, he said, although policies are still being worked out to determine how the data will be accessed.


Related Articles

VA Patients Lack Testing to Optimize CLL Treatment

SALT LAKE CITY — The presence of deletion 17p (del17), determined by chromosome analysis and/or fluorescence in situ hybridization (FISH), is a strong negative prognostic marker in chronic lymphocytic leukemia (CLL), according to a report in the Journal of Clinical Oncology.1

Lobectomy Still Has Significant Survival Benefit in Early NSCLC

While increased use of stereotactic body radiation might have played a key role in doubling survival rates for early-stage non-small cell lung cancer (NSCLC) among veterans between 2001 and 2010 compared to conventional radiation, a new study confirms that isn’t always the best way to assure longer survival.


U.S. Medicine Recommends


More From hhs and usphs

Department of Defense (DoD)

Telemedicine Allows Army, Indian Health Service to Expand Range of Diabetes Care

To reach the growing number of individuals in their care who have diabetes, both the Army and the Indian Health Service have aggressively adopted telemedicine

Pharmacists Play Big Role in More-Restrictive IHS Opioid Prescribing Rules

BRONX, NY — For patients with chronic kidney disease (CKD), living more than 30 miles from their nephrologist is associated with many unfavorable outcomes. They have lower rates of clinic visit adherence, more limited access... View Article

Study Determines Patients Most Vulnerable to E. Coli H30

BRONX, NY — For patients with chronic kidney disease (CKD), living more than 30 miles from their nephrologist is associated with many unfavorable outcomes. They have lower rates of clinic visit adherence, more limited access... View Article

HHS and USPHS

Stroke Kills Young American Indian/Alaska Natives at Twice Rate of Whites

BRONX, NY — For patients with chronic kidney disease (CKD), living more than 30 miles from their nephrologist is associated with many unfavorable outcomes. They have lower rates of clinic visit adherence, more limited access... View Article

Department of Defense (DoD)

Uniformed Pharmacists Take Half of Next Generation Pharmacist Awards

BRONX, NY — For patients with chronic kidney disease (CKD), living more than 30 miles from their nephrologist is associated with many unfavorable outcomes. They have lower rates of clinic visit adherence, more limited access... View Article

Facebook Comment

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up